Ultrafiltration for Outer Membrane Vesicle Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current processes for preparing outer membrane vesicles (OMVs) for vaccines are inefficient, particularly in terms of time and scalability, as they rely on centrifugation steps that are time-consuming and labor-intensive, limiting the production of OMVs for industrial-scale use.
Innovation Solution
The use of ultrafiltration replaces centrifugation steps in the OMV preparation process, allowing for the processing of larger volumes of OMV-containing supernatants in a shorter time, thereby eliminating the need for certain centrifugation steps and improving the efficiency of OMV purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If centrifugation is used to separate OMVs from cell debris, then OMV purification is achieved, but the process becomes time-consuming and labor-intensive
Solution Approach 1:
The patent replaces the mechanical centrifugation system with an ultrafiltration system using a filtration membrane. The ultrafiltration membrane selectively separates OMVs from cell debris based on size differences, eliminating the need for high-speed centrifugation and significantly reducing process time while maintaining purification effectiveness.
Solution Approach 2:
The patent employs a porous ultrafiltration membrane with specific pore sizes to separate OMVs from cell debris. The membrane's porous structure allows smaller molecules and debris to pass through while retaining larger OMVs, providing an efficient and time-effective purification method compared to centrifugation.
2Manufacturing precision
If centrifugation steps are used in OMV preparation, then OMV separation is achieved, but scalability for industrial use is limited
Solution Approach 1:
The patent replaces mechanical centrifugation with ultrafiltration, which can be more easily scaled up for industrial applications. The ultrafiltration system allows for continuous processing of larger volumes of bacterial culture filtrate, making it suitable for industrial-scale OMV production while maintaining effective separation.
Solution Approach 2:
The ultrafiltration membrane serves multiple functions simultaneously: it separates OMVs from cell debris, concentrates the OMV preparation, and can be configured for continuous operation. This multi-functionality enhances scalability and productivity compared to centrifugation, which requires multiple discrete steps and larger equipment footprints.
3Manufacturing precision
If traditional centrifugation-based processes are used, then OMV preparation is achieved, but the process becomes complex and labor-intensive
Solution Approach 1:
The patent simplifies the process by replacing complex centrifugation steps with a single ultrafiltration operation. The ultrafiltration membrane performs separation and concentration in one step, reducing the number of equipment changes, process transitions, and operational complexities associated with multi-step centrifugation protocols.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Ultrafiltration enables the rapid preparation of larger quantities of OMVs, simplifying the process, reducing time, and maintaining the native conformation of proteins, thus enhancing the scalability and efficiency of OMV production for vaccine development.
Implementation Method 1
a step of ultrafiltration of an OMV suspension in place of a step of centrifugation
Data Source
AI summary
In place of a step of centrifugation during preparation of outer membrane vesicles (OMVs) from bacteria, the invention utilizes ultrafiltration. This allows much larger amounts of OMV-containing supernatant to be processed in a much shorter time. Thus the invention provides a process for preparing bacterial OMVs, comprising a step of ultrafiltration. The ultrafiltration step is performed on an aqueous suspension of OMVs after they have been prepared from bacteria and the OMVs remain in suspension after the filtration step. The invention is particularly useful for preparing OMVs from Neisseria meningitidis.